Antelope Surgical Solutions, Inc
AS1986NS
Prostate Cancer
Countdown
86days
Phase 2 readout · ~ Sep 30, 2026 estimated
What's at stake
Phase 2 trial results for AS1986NS in Prostate Cancer are due ~ Sep 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 13h ago
“CT.gov NCT06906471: Phase 2 trial, sponsor Antelope Surgical Solutions, Inc, drug AS1986NS. Primary completion date 2026-09-30 (estimated).”